Standout Papers

The Measurement of Observer Agreement for Categorical Data 1969 2026 1988 2007 57.3k
  1. The Measurement of Observer Agreement for Categorical Data (1977)
    J. Richard Landis, Gary G. Koch Biometrics
  2. An Application of Hierarchical Kappa-type Statistics in the Assessment of Majority Agreement among Multiple Observers (1977)
    J. Richard Landis, Gary G. Koch Biometrics
  3. U. S. Householder survey of functional gastrointestinal disorders (1993)
    Douglas A. Drossman, Zhiming Li et al. Digestive Diseases and Sciences
  4. Analysis of Categorical Data by Linear Models (1969)
    James E. Grizzle, C F Starmer et al. Biometrics
  5. Secondary Sexual Characteristics and Menses in Young Girls Seen in Office Practice: A Study from the Pediatric Research in Office Settings Network (1997)
    Marcia E. Herman‐Giddens, Eric J. Slora et al. PEDIATRICS
  6. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis (2022)
    Steven R. Ytterberg, Deepak L. Bhatt et al. New England Journal of Medicine
  7. Assessment of Risk for Periodontal Disease. I. Risk Indicators for Attachment Loss (1994)
    Sara G. Grossi, Joseph J. Zambon et al. Journal of Periodontology
  8. Lifetime risk of symptomatic knee osteoarthritis (2008)
    Louise B. Murphy, Todd A. Schwartz et al. Arthritis Care & Research
  9. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension (2002)
    Ronald J. Raymond, Alan L. Hinderliter et al. Journal of the American College of Cardiology
  10. Assessment of Risk for Periodontal Disease. II. Risk Indicators for Alveolar Bone Loss (1995)
    Sara G. Grossi, Robert J. Genco et al. Journal of Periodontology
  11. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease (2017)
    Vicente E. Torres, Arlene B. Chapman et al. New England Journal of Medicine
  12. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials (2020)
    Beth A. Davison, Stephen A. Harrison et al. Journal of Hepatology
  13. Age estimation up to 16 years of age based on dental development. (1974)
    Gösta Gustafson, Gary G. Koch PubMed
  14. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance (2022)
    Christina Charles‐Schoeman, Maya H Buch et al. Annals of the Rheumatic Diseases

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Ulcerative colitis
2023 Standout
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
2023 Standout
5 intermediate papers

Works of Gary G. Koch being referenced

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
2022 Standout
The Measurement of Observer Agreement for Categorical Data
1977 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Gary G. Koch 3460 1383 4814 12420 8073 475 85.8k
J. Richard Landis 2062 810 3022 11951 8129 244 77.2k
Jos Kleijnen 556 314 7442 16793 10365 312 86.4k
Henrica C. W. de Vet 562 336 2335 13658 5839 518 66.5k
Jonathan A C Sterne 2892 228 7358 12776 11572 380 80.4k
L.M. Bouter 335 201 6760 18022 9485 621 85.6k
Paul Glasziou 1377 304 6956 9945 7874 622 64.4k
George A. Wells 674 94 13766 17537 9142 864 86.7k
Víctor M. Montori 1292 187 7053 13008 9250 678 74.4k
Jonathan J Deeks 1602 159 8570 18953 15953 346 90.3k
P.J. Devereaux 1357 353 16224 23695 9776 395 91.9k

All Works

Loading papers...

Rankless by CCL
2026